MedTrace Logo

Combined CXL//UV and PRK or LASIK in Forme Fruste Keratoconus or Eyes With Potential Risk of Ectasia

NCT01726283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2015-08-24

No results posted yet for this study

Summary

This study is being performed to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) in strengthening and optimizing the biomechanical and biochemical stability of the cornea in patients with fruste keratoconus (FFKC), corneas that are suspicious for FFKC and corneas thought to be at higher risk of developing ectasia that will be undergoing laser vision correction.

Conditions

  • Fruste Keratoconus
  • Risk of Ectasia

Interventions

DEVICE

Corneal Cross-Linking

Corneal cross-linking procedure conducted during vision correction surgery.

DRUG

Riboflavin

Riboflavin will be instilled prior to corneal cross linking.

Sponsors & Collaborators

  • Cxlusa

    lead INDUSTRY

Principal Investigators

  • William Trattler, MD · Center For Excellence In Eye Care

  • Roy Rubinfeld · CXL-USA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01726283 on ClinicalTrials.gov